Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wisconsin Health Press.
Press releases published on August 20, 2025
BioAegis Therapeutics Awarded Second FDA Fast Track Designation for Recombinant Human Gelsolin to Treat Inflammasome-Driven Decompression Sickness (DCS)
GlobeNewswire
·
August 20, 2025
Fast Track status accelerates regulatory pathway for BioAegis’ recombinant human plasma gelsolin (rhu-pGSN), a novel immune modulator for inflammatory diseases. Second Fast Track designation in recent months highlights broad potential of rhu-pGSN across …
EYLEA HD® (aflibercept) Injection 8 mg Applications for Expanded U.S. Label and Prefilled Syringe Receive FDA Review Period Extension
GlobeNewswire
·
August 20, 2025
TARRYTOWN, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has extended the target action dates to the fourth quarter of 2025 for two EYLEA HD® ( …
Glaucoma Research Foundation Launches Treatment Accelerator with Transformative $5 Million Gift
GlobeNewswire
·
August 20, 2025
SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Glaucoma Research Foundation is proud to announce it received a transformative $5 million gift from the John and Daria Barry Foundation, the largest single donation in the organization’s history. The …
InfoAging Launches Florida’s First Comprehensive “Care Team Finder” to Tackle Senior Health Crisis
GlobeNewswire
·
August 20, 2025
Miami, Florida, Aug. 20, 2025 (GLOBE NEWSWIRE) -- InfoAging, a specialized health directory for senior-focused care, today announced the launch of InfoAging.org, Florida’s first comprehensive “Care Team Finder” platform. Designed to address the state’s …
Keros Announces U.S. FDA Orphan Drug Designation Granted to KER-065 for the Treatment of Duchenne Muscular Dystrophy
GlobeNewswire
·
August 20, 2025
LEXINGTON, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders …
Sustainability & Nutrition Drives Pea Protein Market Expansion | Europe Leads Global Market Growth
GlobeNewswire
·
August 20, 2025
Delray Beach, FL, Aug. 20, 2025 (GLOBE NEWSWIRE) -- According to a recent research report published by MarketsandMarkets, the pea protein market was valued at USD 2.1 billion in 2024 and projected to reach USD 3.7 billion by 2029, growing at a robust CAGR …
Noble Capital Markets Initiates Equity Research Coverage on Greenwich LifeSciences
GlobeNewswire
·
August 20, 2025
STAFFORD, Texas, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy …
Longeveron® to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
August 20, 2025
MIAMI, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions, today announced …
Calidi Biotherapeutics Announces Pricing of $6 Million Underwritten Public Offering
GlobeNewswire
·
August 20, 2025
SAN DIEGO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic …
American Kidney Fund Launches Podcast, 'The Kidney Collective'
GlobeNewswire
·
August 20, 2025
ROCKVILLE, Md., Aug. 20, 2025 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is proud to announce the launch of its first-ever podcast, "The Kidney Collective™." Introduced as a seven-episode, limited series, The Kidney Collective gives an intimate …
Regulatory Approval Granted for Commencement of Trinity Biotech’s Offshored and Outsourced Manufacturing of its Flagship Rapid HIV Test, Facilitating Strategic and Financial Performance Transformation
GlobeNewswire
·
August 20, 2025
Approval Facilitates Immediate Offshored and Outsourced Manufacturing Strategic Offshore Manufacturing Move Expected to Drive Gross Margin Expansion, Free Up Working Capital, and Enhance Scalability Transition to Outsourced Production Reduces Fixed Costs …
Eleos Launches AI Scanner to Navigate Medicaid Eligibility Risk in Real Time
GlobeNewswire
·
August 20, 2025
BOSTON, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Eleos, the leading AI platform in post-acute care, today announced the launch of the OBBBA (One Big Beautiful Bill Act) AI scanner, the first real-time tool to proactively detect potential changes to Medicaid …
Femasys Secures UK Regulatory Approval of FemBloc Permanent Birth Control
GlobeNewswire
·
August 20, 2025
--Advances European commercialization strategy following CE mark approval-- ATLANTA, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and …
Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share
GlobeNewswire
·
August 20, 2025
WALTHAM, Mass. and DUBLIN and EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company (“Mural”), and XOMA Royalty Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator (“ …
Earth Science Tech, Inc. Boosts Share Repurchase Program to $10 Million and Extends Authorization Through 2027
GlobeNewswire
·
August 20, 2025
Miami, Fla., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential businesses, today announced its Board of Directors has approved a …
Option Care Health Announces Chief Financial Officer Transition
GlobeNewswire
·
August 20, 2025
BANNOCKBURN, Ill., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced the appointment of …
Easy Environmental Solutions Launches Terreplenish Trials in Tanzania, Opening Door to Multi-Unit Deployment
GlobeNewswire
·
August 20, 2025
MANKATO, Minn., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Digital Utilities Ventures, Inc. (OTC: DUTV), operating as Easy Environmental Solutions Inc., today announced a strategic collaboration with the Tanzania Fertilizer Regulatory Authority (TFRA) to advance …
Dror Ortho-Design Launches Global ZSmile Innovation Network Initiative to Transform the Stagnating Aligner Market
GlobeNewswire
·
August 20, 2025
JERUSALEM, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Dror Ortho-Design, Inc. (OTC PINK: DROR), a pioneer in AI-powered orthodontic solutions, today announced the launch of the ZSmile Innovation Network, a global community of dental professionals committed to …
Vivani Medical CEO Adam Mendelsohn to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025
GlobeNewswire
·
August 20, 2025
ALAMEDA, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, announced today that CEO Adam Mendelsohn, …
Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications
GlobeNewswire
·
August 20, 2025
With the Newly Granted IP, the Company’s IP Portfolio for the LIBERTY® System now includes 12 patents granted globally and 57 patent applications pending. The Company Continues to Scale Commercial Readiness Plans for the LIBERTY® System as it Awaits FDA …